Halozyme Therapeutics Inc
(NASDAQ:HALO)
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
top performing HALO trades
![Josh Gottheimer headshot](https://clerk.house.gov/content/assets/img/members/G000583.jpg)
Josh Gottheimer
House (D-NJ)
22.10%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Halozyme Therapeutics trades made by congress members.
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale | Aug 13, 2023 | Jul 12, 2023 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale (Partial) | Jan 13, 2023 | Dec 06, 2022 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Sep 16, 2022 | Aug 05, 2022 | House |